| U.S. healthcare spending to climb 5.3 percent in 2018: agency | | | WASHINGTON (Reuters) - United States health spending is projected to rise 5.3 percent in 2018, reflecting rising prices of medical goods and services and higher Medicaid costs, a U.S. government health agency said on Wednesday, an upward trend it forecasts for the next decade. |
| |
| Indivior legal costs rise, new anti-addiction drug ready | | | LONDON (Reuters) - Britain's Indivior, which makes drugs to treat opioid addiction and plans to launch a key new product this month, said on Thursday it had increased provisions for investigative and antitrust litigation matters to $438 million. |
| |
| FDA approves J&J prostate cancer treatment | | | (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's Erleada for use in prostate cancer patients whose disease has not spread but continues to grow despite hormone therapy. |
| |
| Postpartum depression can linger for years and impact kids’ behavior | | | (Reuters Health) - Women whose postpartum depression lasts for several months are at heightened risk of having depression that lingers for years and it may affect their children, showing up as behavior problems and increased depression risk in the teenage years, a UK study suggests. |
| |
| Trauma support may help low-income families earn more | | | (Reuters Health) - A federal assistance program designed to move low-income families toward financial independence comes up short – but results might improve if families also receive support that helps them deal with traumatic experiences, a new study suggests. |
| |
| | |
